MedTrace Logo

Impact of Corona Vaccination on AMH- Anti Mullerian Hormone

NCT05034679 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2021-09-05

No results posted yet for this study

Summary

Since December 2020 Nationwide anti-COVID-19 vaccination began in Israel using the Pfizer - BioNtech vaccine (BNT162b2 mRNA). The vaccination campaign has been associated with concerns regarding potential detrimental effects on future fertility. The aim of the study is to determine the impact of COVID-19 vaccination on n AMH- Anti Mullerian Hormone which express ovarin function.

disease and/or immunization on human follicular function, by comparing follicular steroidogenesis, response to the LH/hCG trigger, and oocyte quality biomarker (HSPG2), in the aspirated follicular fluid of patients undergoing ovum pick-up.

Conditions

  • Patient Participation

Interventions

BIOLOGICAL

Vcinated

Patients who were vacinated.

Sponsors & Collaborators

  • Wolfson Medical Center

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2022-08-15
Completion
2022-10-15

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05034679 on ClinicalTrials.gov